MolecuLight, a leading medical imaging company, is known for its creation and commercialization of exclusive fluorescent imaging innovation in diverse clinical markets. Presently, the organization announces its partnership with Tissue Analytics’ unified platform for consistent amalgamation of MolecuLight i:X® device with noticeable EMR/EHR platforms.

Tissue Analytics creates AI-controlled programming solutions to assist clinicians, payers, research stakeholders, and businesses in numerous treatment areas. Their platform uses sophisticated computer vision and machine learning to augment documentation workflows and enhance the quality of EMR data.

“As the use of our MolecuLight i:X platform is growing rapidly across multiple healthcare settings, so too is the need for EHR integration of our standard images, fluorescence images, and digital wound measurements,” stated Anil Amlani, MolecuLight’s CEO.

Wound care clinicians using both MolecuLight and Tissue Analytics can quickly send across both the fluorescence and standard images captured with the MolecuLight i:X tool to the EMR/EHR. This integrated approach lets them optimize their regular workflow as well as store the patient’s wounds digitally. Aside from this news, the company is propelling direct integration capabilities amongst the MolecuLight i:X with driving EMR/EHR gadgets.

Anil Amlani is proud of this alliance as he said, “We are proud to announce our strategic alliance with Tissue Analytics to integrate with a wide variety of EMR/EHR platforms to provide documentation of patient’s wounds, including wound measurement and changes in bacterial burden.”

“The MolecuLight i:X is the only point-of-care device enabling clinicians to capture wound images that depict the presence of clinically significant bacteria, and these are extremely helpful in informing clinical decision making to ensure the fastest path to healing. The integration with Tissue Analytics will greatly assist in integrating this additional information into existing documentation protocols,” he added.

Along with better-quality digital documentation and workflow, the integrated MolecuLight and Tissue Analytics’ platforms lets clinicians verify the fluorescence and depths of wounds captured past, to examine the wound progression as well as the effectiveness of its treatment. The clinics with different MolecuLight i:X devices in different areas can spare and access the injury pictures and their estimations utilizing EMR/EHR. In addition, the fluorescence pictures known to improve wound assessment precision for distinguishing the ones with microscopic organisms at 104 CFU/g or more will be transferred to the patient record. This data offers a comprehensive dataset to make informed choices and treatment policies.